Correlation between the serum values of soluble intercellular adhesion molecule-1 and total sialic acid levels in patients with breast cancer. 2007

M Basoglu, and S S Atamanalp, and M I Yildirgan, and B Aydinli, and G Ozturk, and F Akcay, and D Oren
Department of General Surgery, School of Medicine, Ataturk University Erzurum, Erzurum, Turkey. mbasoglu@hotmail.com

BACKGROUND In this study, we aimed to investigate serum total sialic acid (TSA) and soluble intracellular adhesion molecule-1 (sICAM-1) levels in breast cancer patients to find a correlation with the cancer stage. METHODS The parameters from sera of 61 patients with breast cancer were measured. The concentrations of serum sICAM-1 and TSA were measured in serum samples from 61 patients with breast cancer and 25 healthy control subjects using enzyme-linked immunoassay and thiobarbituric acid method. RESULTS Mean serum sICAM-1 and TSA levels were significantly higher in the total patient group than in the control group (p < 0.001). Thus, the correlation between TSA and sICAM-1 became more significant in metastatic breast cancer. There were significant positive correlations between TSA and sICAM-1 in stage I+II (r = 0.59, p < 0.05), stage III (r = 0.47, p < 0.05), and stage IV (r = 0.89, p < 0.01), and total patient group (r = 0.56, p < 0.001). CONCLUSIONS SerumsICAM-1 and TSA levels were higher in patients with breast cancer, than that of the control group, and also in the metastatic breast cancer group. Significant correlations between serum sICAM-1 and TSA may reflect the similar function of these molecules as adhesion molecules, and their roles in the carcinogenesis of breast cancer as well as metastasis.

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D001943 Breast Neoplasms Tumors or cancer of the human BREAST. Breast Cancer,Breast Tumors,Cancer of Breast,Breast Carcinoma,Cancer of the Breast,Human Mammary Carcinoma,Malignant Neoplasm of Breast,Malignant Tumor of Breast,Mammary Cancer,Mammary Carcinoma, Human,Mammary Neoplasm, Human,Mammary Neoplasms, Human,Neoplasms, Breast,Tumors, Breast,Breast Carcinomas,Breast Malignant Neoplasm,Breast Malignant Neoplasms,Breast Malignant Tumor,Breast Malignant Tumors,Breast Neoplasm,Breast Tumor,Cancer, Breast,Cancer, Mammary,Cancers, Mammary,Carcinoma, Breast,Carcinoma, Human Mammary,Carcinomas, Breast,Carcinomas, Human Mammary,Human Mammary Carcinomas,Human Mammary Neoplasm,Human Mammary Neoplasms,Mammary Cancers,Mammary Carcinomas, Human,Neoplasm, Breast,Neoplasm, Human Mammary,Neoplasms, Human Mammary,Tumor, Breast
D002450 Cell Communication Any of several ways in which living cells of an organism communicate with one another, whether by direct contact between cells or by means of chemical signals carried by neurotransmitter substances, hormones, and cyclic AMP. Cell Interaction,Cell-to-Cell Interaction,Cell Communications,Cell Interactions,Cell to Cell Interaction,Cell-to-Cell Interactions,Communication, Cell,Communications, Cell,Interaction, Cell,Interaction, Cell-to-Cell,Interactions, Cell,Interactions, Cell-to-Cell
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D016022 Case-Control Studies Comparisons that start with the identification of persons with the disease or outcome of interest and a control (comparison, referent) group without the disease or outcome of interest. The relationship of an attribute is examined by comparing both groups with regard to the frequency or levels of outcome over time. Case-Base Studies,Case-Comparison Studies,Case-Referent Studies,Matched Case-Control Studies,Nested Case-Control Studies,Case Control Studies,Case-Compeer Studies,Case-Referrent Studies,Case Base Studies,Case Comparison Studies,Case Control Study,Case Referent Studies,Case Referrent Studies,Case-Comparison Study,Case-Control Studies, Matched,Case-Control Studies, Nested,Case-Control Study,Case-Control Study, Matched,Case-Control Study, Nested,Case-Referent Study,Case-Referrent Study,Matched Case Control Studies,Matched Case-Control Study,Nested Case Control Studies,Nested Case-Control Study,Studies, Case Control,Studies, Case-Base,Studies, Case-Comparison,Studies, Case-Compeer,Studies, Case-Control,Studies, Case-Referent,Studies, Case-Referrent,Studies, Matched Case-Control,Studies, Nested Case-Control,Study, Case Control,Study, Case-Comparison,Study, Case-Control,Study, Case-Referent,Study, Case-Referrent,Study, Matched Case-Control,Study, Nested Case-Control
D018799 Intercellular Adhesion Molecule-1 A cell-surface ligand involved in leukocyte adhesion and inflammation. Its production is induced by gamma-interferon and it is required for neutrophil migration into inflamed tissue. Antigens, CD54,CD54 Antigens,ICAM-1,CD54 Antigen,Antigen, CD54,Intercellular Adhesion Molecule 1
D019158 N-Acetylneuraminic Acid An N-acyl derivative of neuraminic acid. N-acetylneuraminic acid occurs in many polysaccharides, glycoproteins, and glycolipids in animals and bacteria. (From Dorland, 28th ed, p1518) Sialic Acid,Acid, N-Acetylneuraminic,Acid, Sialic,N Acetylneuraminic Acid

Related Publications

M Basoglu, and S S Atamanalp, and M I Yildirgan, and B Aydinli, and G Ozturk, and F Akcay, and D Oren
December 2001, Japanese journal of clinical oncology,
M Basoglu, and S S Atamanalp, and M I Yildirgan, and B Aydinli, and G Ozturk, and F Akcay, and D Oren
July 2005, Lin chuang er bi yan hou ke za zhi = Journal of clinical otorhinolaryngology,
M Basoglu, and S S Atamanalp, and M I Yildirgan, and B Aydinli, and G Ozturk, and F Akcay, and D Oren
January 1997, Anticancer research,
M Basoglu, and S S Atamanalp, and M I Yildirgan, and B Aydinli, and G Ozturk, and F Akcay, and D Oren
February 2003, Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences,
M Basoglu, and S S Atamanalp, and M I Yildirgan, and B Aydinli, and G Ozturk, and F Akcay, and D Oren
January 1993, The British journal of dermatology,
M Basoglu, and S S Atamanalp, and M I Yildirgan, and B Aydinli, and G Ozturk, and F Akcay, and D Oren
December 2004, Journal of geriatric psychiatry and neurology,
M Basoglu, and S S Atamanalp, and M I Yildirgan, and B Aydinli, and G Ozturk, and F Akcay, and D Oren
January 2002, Rheumatology international,
M Basoglu, and S S Atamanalp, and M I Yildirgan, and B Aydinli, and G Ozturk, and F Akcay, and D Oren
January 1995, International journal of clinical & laboratory research,
M Basoglu, and S S Atamanalp, and M I Yildirgan, and B Aydinli, and G Ozturk, and F Akcay, and D Oren
May 1999, Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi,
M Basoglu, and S S Atamanalp, and M I Yildirgan, and B Aydinli, and G Ozturk, and F Akcay, and D Oren
November 1999, Breast cancer research and treatment,
Copied contents to your clipboard!